4119 Cholecystokinin (CCK) Receptor Antagonist Reverses Nonalcoholic Steatohepatitis (NASH) by Reducing Hepatic Macrophages and Inflammatory Cytokines
OBJECTIVES/GOALS: NASH increases the risk of cirrhosis and liver cancer. High-fat diets increase CCK levels and CCK receptors have been identified on fibroblasts and immune cells. We hypothesized that CCK receptor blockade could prevent NASH by altering the hepatic microenvironment and macrophage ac...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Cambridge University Press
2020-06-01
|
| סדרה: | Journal of Clinical and Translational Science |
| גישה מקוונת: | https://www.cambridge.org/core/product/identifier/S2059866120002939/type/journal_article |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|